Anti-Cholera Toxin antibody produced in rabbit
SIGMA/C3062 - whole antiserum
Synonym: Cholera Toxin Antibody
MDL Number: MFCD00162231
Product Type: Chemical
ELISA Anti-Cholera Toxin antibody produced in Rabbit (Cat. No. C3062), followed by 1:5,000 Anti-Rabbit IgG (whole molecule)-Peroxidase antibody produced in Goat (Cat. No. A0545), was serially diluted to detect Chicken Egg Albumin by indirect ELISA.
| antibody form | whole antiserum |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| conjugate | unconjugated |
| contains | 15 mM sodium azide |
| Quality Level | 200  |
| shipped in | dry ice |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | dot blot: 1:20,000 |
| indirect ELISA: 1:8,000 | |
| Ouchterlony double diffusion: 1:16 |
| Application: | Anti-Cholera Toxin antibody produced in rabbit has been used in: • western blotting • quantitative ganglioside-dependent enzyme-linked immunoassay (ELISA) • double immunodiffusion |
| Biochem/physiol Actions: | Cholera toxin (CT), a multifunctional protein plays a role in the immune system. It possesses immunomodulatory, adjuvant properties and also acts as an anti-inflammatory agent. Its immunomodulatory properties can be utilized to treat several autoimmune disorders. CT can serve as one of the best model of a multifunctional protein. |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | Cholera toxin, the pathogenic agent of cholera, is made of two subunits, A (27 kDa) and B (12 kDa) assembled with the stoichiometry AB5. The B-subunit binds to specific receptors, the monosialogangliosides GM1, located in the membrane of intestinal epithelial cells. The A1 fragment of the A-subunit is translocated through the membrane of the host cell, where it catalyses the ADP-ribosylation of the Gsa regulatory component of the adenylate cyclase complex. The resulting increased level of cyclic AMP promotes a wide variety of actions, including the secretion of chloride ions in the case of intestinal epithelial cells. |
| General description: | The antiserum reacts versus Cholera toxin, but shows no reaction versus Staphylococcal enterotoxin A, Staphylococcal enterotoxin B and Pseudomonas exotoxin A (protein concentration: 50-500 ng/dot). The product has not been tested for neutralization potency against active Cholera toxin. |
| Immunogen: | toxin from Vibrio cholerae |
| Preparation Note: | delipidized |
| Hazard Codes | Xn |
| Risk Statements | 21/22 |
| Safety Statements | 36/37-60 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |